SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Money M. E.)
 

Search: WFRF:(Money M. E.) > Adverse maternal, f...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005505naa a2201141 4500
001oai:prod.swepub.kib.ki.se:152011311
003SwePub
008240701s2023 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1520113112 URI
024a https://doi.org/10.1136/bmjgh-2022-0094952 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Smith, ER4 aut
2451 0a Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis
264 c 2023-01-16
264 1b BMJ,c 2023
520 a Despite a growing body of research on the risks of SARS-CoV-2 infection during pregnancy, there is continued controversy given heterogeneity in the quality and design of published studies.MethodsWe screened ongoing studies in our sequential, prospective meta-analysis. We pooled individual participant data to estimate the absolute and relative risk (RR) of adverse outcomes among pregnant women with SARS-CoV-2 infection, compared with confirmed negative pregnancies. We evaluated the risk of bias using a modified Newcastle-Ottawa Scale.ResultsWe screened 137 studies and included 12 studies in 12 countries involving 13 136 pregnant women.Pregnant women with SARS-CoV-2 infection—as compared with uninfected pregnant women—were at significantly increased risk of maternal mortality (10 studies; n=1490; RR 7.68, 95% CI 1.70 to 34.61); admission to intensive care unit (8 studies; n=6660; RR 3.81, 95% CI 2.03 to 7.17); receiving mechanical ventilation (7 studies; n=4887; RR 15.23, 95% CI 4.32 to 53.71); receiving any critical care (7 studies; n=4735; RR 5.48, 95% CI 2.57 to 11.72); and being diagnosed with pneumonia (6 studies; n=4573; RR 23.46, 95% CI 3.03 to 181.39) and thromboembolic disease (8 studies; n=5146; RR 5.50, 95% CI 1.12 to 27.12).Neonates born to women with SARS-CoV-2 infection were more likely to be admitted to a neonatal care unit after birth (7 studies; n=7637; RR 1.86, 95% CI 1.12 to 3.08); be born preterm (7 studies; n=6233; RR 1.71, 95% CI 1.28 to 2.29) or moderately preterm (7 studies; n=6071; RR 2.92, 95% CI 1.88 to 4.54); and to be born low birth weight (12 studies; n=11 930; RR 1.19, 95% CI 1.02 to 1.40). Infection was not linked to stillbirth. Studies were generally at low or moderate risk of bias.ConclusionsThis analysis indicates that SARS-CoV-2 infection at any time during pregnancy increases the risk of maternal death, severe maternal morbidities and neonatal morbidity, but not stillbirth or intrauterine growth restriction. As more data become available, we will update these findings per the published protocol.
700a Oakley, E4 aut
700a Grandner, GW4 aut
700a Ferguson, K4 aut
700a Farooq, F4 aut
700a Afshar, Y4 aut
700a Ahlberg, Mu Karolinska Institutet4 aut
700a Ahmadzia, H4 aut
700a Akelo, V4 aut
700a Aldrovandi, G4 aut
700a Barr, BAT4 aut
700a Bevilacqua, E4 aut
700a Brandt, JS4 aut
700a Broutet, N4 aut
700a Buhigas, IF4 aut
700a Carrillo, J4 aut
700a Clifton, R4 aut
700a Conry, J4 aut
700a Cosmi, E4 aut
700a Crispi, F4 aut
700a Crovetto, F4 aut
700a Delgado-Lopez, C4 aut
700a Divakar, H4 aut
700a Driscoll, AJ4 aut
700a Favre, G4 aut
700a Flaherman, VJ4 aut
700a Gale, C4 aut
700a Gil, MM4 aut
700a Gottlieb, SL4 aut
700a Gratacos, E4 aut
700a Hernandez, O4 aut
700a Jones, S4 aut
700a Kalafat, E4 aut
700a Khagayi, S4 aut
700a Knight, M4 aut
700a Kotloff, K4 aut
700a Lanzone, A4 aut
700a Le Doare, K4 aut
700a Lees, C4 aut
700a Litman, E4 aut
700a Lokken, EM4 aut
700a Longo, VL4 aut
700a Madhi, SA4 aut
700a Magee, LA4 aut
700a Martinez-Portilla, RJ4 aut
700a McClure, EM4 aut
700a Metz, TD4 aut
700a Miller, ES4 aut
700a Money, D4 aut
700a Moungmaithong, S4 aut
700a Mullins, E4 aut
700a Nachega, JB4 aut
700a Nunes, MC4 aut
700a Onyango, D4 aut
700a Panchaud, A4 aut
700a Poon, LC4 aut
700a Raiten, D4 aut
700a Regan, L4 aut
700a Rukundo, G4 aut
700a Sahota, D4 aut
700a Sakowicz, A4 aut
700a Sanin-Blair, J4 aut
700a Soderling, Ju Karolinska Institutet4 aut
700a Stephansson, Ou Karolinska Institutet4 aut
700a Temmerman, M4 aut
700a Thorson, A4 aut
700a Tolosa, JE4 aut
700a Townson, J4 aut
700a Valencia-Prado, M4 aut
700a Visentin, S4 aut
700a von Dadelszen, P4 aut
700a Waldorf, KA4 aut
700a Whitehead, C4 aut
700a Yassa, M4 aut
700a Tielsch, JM4 aut
710a Karolinska Institutet4 org
773t BMJ global healthd : BMJg 8:1q 8:1x 2059-7908
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:152011311
8564 8u https://doi.org/10.1136/bmjgh-2022-009495

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view